Management of circumscribed choroidal hemangioma at a tertiary care center.


Journal

International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294

Informations de publication

Date de publication:
02 Jul 2024
Historique:
received: 10 09 2023
accepted: 26 06 2024
medline: 3 7 2024
pubmed: 3 7 2024
entrez: 2 7 2024
Statut: epublish

Résumé

To review long-term outcomes of circumscribed choroidal hemangioma (CCH). Hospital charts of all CCH cases diagnosed from 2008 to 2019 were retrospectively reviewed. All 172 patients were managed with either observation, transpupillary thermotherapy, argon laser photocoagulation, photodynamic therapy, plaque brachytherapy or stereotactic radiosurgery. The most common 3 modes of management were clinical observation (30.2%), transpupillary thermotherapy (52.9%) and argon laser photocoagulation (8.7%). Median follow-up time was 10 months (range: 3, 160). Anatomical outcomes were stable in 87.1% of observation group and improved in 60.5% of thermotherapy group. Quantified optical coherence tomography angiography findings showed statistical differences in vascular and perfusion densities in fellow eyes of hemangioma patients. Circumscribed choroidal hemangioma can be treated in various ways. Transpupillary thermotherapy is an anatomically effective treatment in selected cases. The diagnosis of CCH may have vascular implications in fellow eyes of the patients.

Identifiants

pubmed: 38955894
doi: 10.1007/s10792-024-03238-y
pii: 10.1007/s10792-024-03238-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

307

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature B.V.

Références

Witschel H, Font RL (1976) Hemangioma of the choroid. A clinicopathologic study of 71 cases and a review of the literature. Surv Ophthalmol 20:415–31. https://doi.org/10.1016/0039-6257(76)90067-9
doi: 10.1016/0039-6257(76)90067-9 pubmed: 820013
Shields CL, Honavar SG, Shields JA, Cater J, Demirci H (2001) Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology 108:2237–48. https://doi.org/10.1016/s0161-6420(01)00812-0
doi: 10.1016/s0161-6420(01)00812-0 pubmed: 11733265
Dalvin LA, Lim LS, Chang M, Udyaver S, Mazloumi M, Vichitvejpaisal P, Su GL, Florakis E, Mashayekhi A, Shields JA, Shields CL (2019) Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases. Saudi J Ophthalmol 33:219–28. https://doi.org/10.1016/j.sjopt.2019.07.002
doi: 10.1016/j.sjopt.2019.07.002 pubmed: 31686962 pmcid: 6819721
Gunduz AK, Mirzayev I, Tetik D, Ozalp Ates FS (2021) Circumscribed choroidal hemangioma: Comparative efficacy of transpupillary thermotherapy, indocyanine green-enhanced transpupillary thermotherapy, and photodynamic therapy and analysis of baseline clinical features effecting treatment outcomes. Photodiagnosis Photodyn Ther 36:102529. https://doi.org/10.1016/j.pdpdt.2021.102529
doi: 10.1016/j.pdpdt.2021.102529 pubmed: 34509682
Duquesne N, Bouchard O, Jean-Louis B, Bievelez B, Grange JD (2002) Argon laser photocoagulation of circumscribed choroidal hemangiomas. J Fr Ophtalmol 25:42–47
pubmed: 11965117
Papastefanou VP, Plowman PN, Reich E, Pavlidou E, Restori M, Hungerford JL, Arora AK, Cohen VML, Sagoo MS (2018) Analysis of long-term outcomes of radiotherapy and verteporfin photodynamic therapy for circumscribed choroidal hemangioma. Ophthalmol Retina 2:842–57. https://doi.org/10.1016/j.oret.2017.12.002
doi: 10.1016/j.oret.2017.12.002 pubmed: 31047538
Kim YT, Kang SW, Lee JI (2011) Gamma knife radiosurgery for choroidal hemangioma. Int J Radiat Oncol Biol Phys 81:1399–404. https://doi.org/10.1016/j.ijrobp.2010.08.016
doi: 10.1016/j.ijrobp.2010.08.016 pubmed: 20950946
Mahdjoubi A, Dendale R, Desjardins L, Lemaitre S, Lumbroso-Le Rouic L, Goudjil F, Cassoux N, Levy-Gabriel C (2019) Treatment of exudative circumscribed choroidal hemangioma: efficacy of fractionated proton therapy (20 Gray relative biological effectiveness in 8 fractions). Retina 39:692–9. https://doi.org/10.1097/IAE.0000000000002002
doi: 10.1097/IAE.0000000000002002 pubmed: 29252976
Chaves L, Messias A, Correa Z, Jorge R (2021) Intravitreal metoprolol for circumscribed choroidal hemangiomas: a phase I clinical trial. Graefes Arch Clin Exp Ophthalmol 259:2837–41. https://doi.org/10.1007/s00417-021-05153-9
doi: 10.1007/s00417-021-05153-9 pubmed: 33914160
Sanz-Marco E, Gallego R, Diaz-Llopis M (2011) Oral propranolol for circumscribed choroidal hemangioma. Case Rep Ophthalmol 2:84–90. https://doi.org/10.1159/000325142
doi: 10.1159/000325142 pubmed: 21475606 pmcid: 3072177
O’Bryhim BE, Li AS, Bayliss SJ, Tychsen L, Lueder GT, Rajagopal R (2019) Successful treatment of an exudative choroidal hemangioma with oral propranolol in a 10-year-old boy. J AAPOS 23:236–238. https://doi.org/10.1016/j.jaapos.2019.02.004
doi: 10.1016/j.jaapos.2019.02.004 pubmed: 30959167 pmcid: 6778008
Tanabe H, Sahashi K, Kitano T, Tomita Y, Saito AM, Hirose H (2013) Effects of oral propranolol on circumscribed choroidal hemangioma: a pilot study. JAMA Ophthalmol 131:1617–1622. https://doi.org/10.1001/jamaophthalmol.2013.5669
doi: 10.1001/jamaophthalmol.2013.5669 pubmed: 24158615
Singh AD, Kaiser PK, Sears JE (2005) Choroidal hemangioma. Ophthalmol Clin North Am 18:151–61. https://doi.org/10.1016/j.ohc.2004.07.004
doi: 10.1016/j.ohc.2004.07.004 pubmed: 15763200
Anand R, Augsburger JJ, Shields JA (1989) Circumscribed choroidal hemangiomas. Arch Ophthalmol 107:1338–42. https://doi.org/10.1001/archopht.1989.01070020408045
doi: 10.1001/archopht.1989.01070020408045 pubmed: 2783066
Shields CL, Dalvin LA, Lim LS, Chang M, Udyaver S, Mazloumi M, Vichitvejpaisal P, Su GL, Florakis E, Mashayekhi A, Shields JA (2020) Circumscribed choroidal hemangioma: visual outcome in the pre-photodynamic therapy era versus photodynamic therapy era in 458 cases. Ophthalmol Retina 4:100–10. https://doi.org/10.1016/j.oret.2019.08.004
doi: 10.1016/j.oret.2019.08.004 pubmed: 31611094
Gunduz K (2004) Transpupillary thermotherapy in the management of circumscribed choroidal hemangioma. Surv Ophthalmol 49:316–27. https://doi.org/10.1016/j.survophthal.2004.02.009
doi: 10.1016/j.survophthal.2004.02.009 pubmed: 15110668
Garcia-Arumi J, Ramsay LS, Guraya BC (2000) Transpupillary thermotherapy for circumscribed choroidal hemangiomas. Ophthalmology 107:351–6. https://doi.org/10.1016/s0161-6420(99)00046-9
doi: 10.1016/s0161-6420(99)00046-9 pubmed: 10690838
Cennamo G, Breve MA, Rossi C, Romano MR, de Crecchio G, Cennamo (2016) Transpupillary thermotherapy as a primary treatment for circumscribed choroidal haemangioma. Acta Ophthalmol 94:e167–e169. https://doi.org/10.1111/aos.12810
doi: 10.1111/aos.12810 pubmed: 26268462
Kim RS, Jain RR, Brown DM, Bretana ME, Kegley EN, Singer MA, Aragon AV, Schefler A (2018) Elevated choroidal thickness and central serous chorioretinopathy in the fellow eyes of patients with circumscribed choroidal hemangioma. Ocul Oncol Pathol 4:375–80. https://doi.org/10.1159/000486864
doi: 10.1159/000486864 pubmed: 30574490 pmcid: 6288715
Sobol EK, Francis JH, Abramson DH, Freund KB, Spaide RF, Barbazetto I (2020) Subfoveal choroidal thickness and vascular architecture in fellow eyes of patients with circumscribed choroidal hemangioma. Retina 40:758–64. https://doi.org/10.1097/IAE.0000000000002438
doi: 10.1097/IAE.0000000000002438 pubmed: 30633085
Boned-Murillo A, Diaz-Barreda MD, Honrubia-Grijalbo A, Esteban-Floria O, Ascaso Puyuelo FJ (2021) Choroidal hemangioma associated with hepatic hemangioma: a case report and literature review. Case Rep Ophthalmol 12:425–32. https://doi.org/10.1159/000514374
doi: 10.1159/000514374 pubmed: 34054496 pmcid: 8136322
Shaikh S, Sanislo S, O’Brien JM, Alcorn D (2001) Congenital circumscribed choroidal haemangioma associated with infantile hepatic haemangioendotheliomatosis. Br J Ophthalmol. https://doi.org/10.1136/bjo.85.5.625a
doi: 10.1136/bjo.85.5.625a pubmed: 11351971 pmcid: 1723976

Auteurs

İrem Koç (İ)

Ocular Oncology Service, Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey. irem.koc@hacettepe.edu.tr.

Aysun Yücel Gençoğlu (A)

Private Practice, Istanbul, Turkey.

Burcu Yücekul (B)

Department of Ophthalmology, University of Health Science, İstanbul Haseki Training and Research Hospital, Istanbul, Turkey.

Özge Deliktaş (Ö)

Department of Ophthalmology, Bursa City Hospital, Bursa, Turkey.

Ebru Öztürk (E)

Department of Biostatistics, Hacettepe University School of Medicine, Ankara, Turkey.

Hayyam Kiratli (H)

Ocular Oncology Service, Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH